Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Gains from Equity Investments (2019 - 2020)

Arcturus Therapeutics Holdings (ARCT) has disclosed Gains from Equity Investments for 2 consecutive years, with $100000.0 as the latest value for Q2 2020.

  • For the quarter ending Q2 2020, Gains from Equity Investments changed N/A year-over-year to $100000.0, compared with a TTM value of $551000.0 through Jun 2020, changed N/A, and an annual FY2020 reading of $263000.0, up 952.0% over the prior year.
  • Gains from Equity Investments was $100000.0 for Q2 2020 at Arcturus Therapeutics Holdings, down from $163000.0 in the prior quarter.
  • Across five years, Gains from Equity Investments topped out at $288000.0 in Q1 2019 and bottomed at $100000.0 in Q2 2020.